Literature DB >> 8088352

Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat.

P Laurant1, A Berthelot.   

Abstract

The aim of this study was to examine the influence of vascular endothelium on the relaxation induced by increased extracellular Mg2+ concentrations on isolated and noradrenaline-precontracted aorta from deoxycorticosterone acetate-salt (DOCA-salt) hypertensive and normotensive rats. In Mg(2+)-free physiologic salt solution (PSS), addition of Mg2+ (0.1-6.0 nM) caused concentration-dependent relaxation of noradrenaline-precontracted aorta with intact or disrupted endothelium. Mg(2+)-induced relaxation in intact aorta, however, was less in DOCA-salt hypertensive rats than in normotensive rats. When endothelium was disrupted, Mg(2+)-induced relaxation was depressed in aorta from both DOCA-salt hypertensive and normotensive rats. The same observations were made in presence of N-nitro-L-arginine methyl ester (L-NAME), an inhibitor of endothelium-derived relaxing factor nitric oxide (EDRF/NO) biosynthesis. Mg(2+)-induced relaxation following contraction with noradrenaline was significantly less in intact aorta treated with L-NAME from DOCA-salt hypertensive rats than in intact aorta from normotensive rats. Indomethacin did not affect Mg(2+)-induced relaxation in intact aorta from normotensive rats whereas indomethacin significantly increased it in DOCA-salt hypertensive rats. It is concluded that (1) Mg(2+)-induced relaxation can be mediated by endothelium-dependent mechanisms implicating EDRF/NO; (2) the influence of EDRF/NO is more pronounced on the impaired Mg(2+)-induced relaxation of aorta from DOCA-salt hypertensive rats; (3) Mg(2+)-induced relaxation seems masked by vasoconstrictor prostaglandin release in DOCA-salt hypertensive rats; (4) these differences between normotensive and hypertensive rats could be related to the impaired endothelial function in aorta from DOCA-salt hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088352     DOI: 10.1016/0014-2999(94)90477-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Association of hypermagnesemia and blood pressure in the critically ill.

Authors:  Leo A Celi; Daniel J Scott; Joon Lee; Rachel Nelson; Seth L Alper; Kenneth J Mukamal; Roger G Mark; John Danziger
Journal:  J Hypertens       Date:  2013-11       Impact factor: 4.844

2.  Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.

Authors:  P Laurant; A Berthelot
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries.

Authors:  E S Dettmann; T F Lüscher; J Flammer; I O Haefliger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-01       Impact factor: 3.117

4.  Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease.

Authors:  Yusuke Sakaguchi; Tatsuya Shoji; Terumasa Hayashi; Akira Suzuki; Morihiro Shimizu; Kensuke Mitsumoto; Hiroaki Kawabata; Kakuya Niihata; Noriyuki Okada; Yoshitaka Isaka; Hiromi Rakugi; Yoshiharu Tsubakihara
Journal:  Diabetes Care       Date:  2012-04-12       Impact factor: 19.112

5.  Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats.

Authors:  Kyubok Jin; Tae Hee Kim; Yeong Hoon Kim; Yang Wook Kim
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.